3:15 PM

Off-the-Shelf and On-Target: How iPSC-Derived CAR T Cells Could Democratize  Autoimmune Cell Therapy 
Bobby Goulding, Fate Therapeutics  

3:45 PM
Development and Characterization of iPSC-Derived Regulatory T cells – Towards an Allogenic Cell Therapy for the Treatment of Autoimmunity and Inflammatory Conditions
Marc Martinez Llordella, PhD, Quell Therapeutics Ltd 

4:15 PM

Designing the Best CARs, Lessons from Cancer
Naomi Taylor, MD, PhD, National Cancer Institute, National Institutes of Health